Literature DB >> 3086237

Epidemiology and risk calculation of hepatitis-B as an occupational disease in the Austrian health service.

H Maruna, G Westphal.   

Abstract

The present investigation of occupation-related cases of hepatitis in the statistics of occupational diseases attempted to quantify the specific risk of this infectious disease for all occupations within the health service. The absolute number of occupation-related cases of hepatitis B increased fourfold over the last two decades, while at the same time the number of health service employees only doubled. In comparison with the Austrian population, the hepatitis risk is about 11 times higher for the health service employees. Especially laboratory personnel, doctors and support service personnel are exposed to these increased risks. The relative risks according to age, sex and type of occupation were also investigated and a comparison was made with the findings of other investigations in Austrian and international specialized literature. First information is also given about the findings of the screening on immunity against HBs-antigen, anti-HBs and anti-HBc in the professional group of health service employees. The calculations, and also experience in other countries, show the need for the introduction of an active protective immunization against hepatitis B for all health service employees. The prophylaxis against hepatitis that was begun in Austria on January 1st, 1983, is the first extensive vaccination programme against this liver disease, that on the basis of research done by a social security institute, has been implemented free of charge by this institute for a professional category.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086237     DOI: 10.1007/bf00406182

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  7 in total

1.  Letter: HBAg in breast milk.

Authors:  C C Linnemann; S Goldberg
Journal:  Lancet       Date:  1974-07-20       Impact factor: 79.321

2.  Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.

Authors:  J Crosnier; P Jungers; A M Couroucé; A Laplanche; E Benhamou; F Degos; B Lacour; P Prunet; Y Cerisier; P Guesry
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

3.  Risk factors in transmission of non-A, non-B posttransfusion hepatitis. The role of hepatitis B antibody in donor blood.

Authors:  M E Conrad; R G Knodell; E L Bradley; E P Flannery; A L Ginsberg
Journal:  Transfusion       Date:  1977 Nov-Dec       Impact factor: 3.157

4.  [Iatrogenic and environmentally induced diseases of the liver in old age: viral hepatitis in old age].

Authors:  W Horak
Journal:  Aktuelle Gerontol       Date:  1983-11

5.  [Hepatitis B contamination of Viennese hospital personnel].

Authors:  P Lorant; E Knapp; H Hofmann; W Frisch-Niggemeyer; H Pichler
Journal:  Wien Klin Wochenschr       Date:  1983-04-01       Impact factor: 1.704

6.  Hepatitis B infection in hospital personnel during an eight-year period; policies for screening and pregnancy in high risk areas.

Authors:  E L Pantelick; A C Steere; H D Lewis; D J Miller
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

7.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.